IMF: Weaker external outlook, rising jobless affect Portugal

VZ beats EPS estimates, boosting shares 3%. Mixed revenue, but strong cash flow outlook signals value.

Teva's pivot shows growth in key drugs like Austedo (34% sales jump). Q1 earnings may dip, but 2027 EPS targets rise 17%.

CVLT drops 4.2% on hold rating; 2027 growth forecast faces risk. Down 27.9% YTD.

Morgan Stanley says dollar risks are increasingly skewed to the downside as FX markets grow less sensitive to energy war headlines, though refined product shortages remain a key upside risk for the currency.

Tesla's $56B Musk pay package revived! Stock dips on valuation concerns, but it's a win for Musk.

Snap jumps 7.9% on Buy upgrade, doubled PT to $10. Analysts eye GAAP profit, but volatility remains.

FBP jumps 3.1% on Strong Buy upgrade, target to $27. Low volatility stock nears 52-week high.